CDK4/6 inhibitor and radiation therapy in malignant pleural mesothelioma.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e24326
Abstract: e24326Background: The prognosis of malignant pleural mesothelioma (MPM) is very poor; a new drug for MPM is need. The percentage of p16 loss in MPM patients is high. We hypothesized that CDK4/6 is ... read more here.
Keywords: cdk4 inhibitor; radiation therapy; inhibitor radiation; pleural mesothelioma ... See more keywords